Skip to main content
ABINGDON HEALTH PLC logo

ABINGDON HEALTH PLC — Investor Relations & Filings

Ticker · ABDX ISIN · GB00BLF79J41 LEI · 213800XFI4WV3FBILO20 IL Manufacturing
Open in API
Filings indexed 261 across all filing types
Latest filing 2022-10-07 Regulatory Filings
Country GB United Kingdom
Listing IL ABDX

About ABINGDON HEALTH PLC

https://www.abingdonhealth.com/

Abingdon Health PLC is a contract development and manufacturing organization (CDMO) that specializes in lateral flow assays, also known as rapid tests. The company provides a comprehensive, fully integrated service to a global customer base, supporting diagnostic projects from initial concept and development through to high-volume automated manufacturing and regulatory support. Its services cater to a wide range of sectors, including clinical, animal health, environmental, and plant health. Abingdon Health also develops and manufactures lateral flow readers and smartphone reader applications, which complement its assay services by enabling digital data capture and analysis.

Recent filings

Filing Released Lang Actions
Price Monitoring Extension
Regulatory Filings Classification · 99% confidence The document explicitly starts with 'RNS Number' and mentions 'RNS, the news service of the London Stock Exchange' and 'Financial Conduct Authority'. The content describes a 'Price Monitoring Extension' for a security, which is a specific, short-form regulatory market announcement regarding trading procedures, not a comprehensive financial report (like 10-K or IR) or a management/shareholder communication. Given its nature as a general regulatory market notice that doesn't fit the highly specific categories (like DIV, DIRS, ER), the most appropriate classification is the general regulatory filing fallback category, RNS.
2022-10-07 English
Judicial Review – judgement expected at 3pm
Regulatory Filings Classification · 98% confidence The document is a short announcement disseminated via RNS (Regulatory News Service), indicated by the 'RNS Number' header and the closing statement referencing RNS and the London Stock Exchange. The content discusses an expected judgement in a Judicial Review proceeding where the company is an interested party, and explicitly states, 'A further announcement will be made once the outcome of the Judicial Review is known.' This structure—a brief update on a specific, non-routine event (legal matter) released through an official news service—fits the definition of a general regulatory announcement that doesn't align with specific financial reports (10-K, IR, ER) or corporate actions (DIV, CAP). Therefore, the most appropriate classification is Regulatory Filings (RNS), which serves as the general category for such official disclosures.
2022-10-07 English
Judicial Review – judgement expected
Regulatory Filings Classification · 98% confidence The document is clearly identified as an RNS (Regulatory News Service) announcement, indicated by the 'RNS Number' header and the concluding paragraph stating, 'This information is provided by RNS, the news service of the London Stock Exchange.' The content discusses an expected judgement in a Judicial Review proceeding where the company is an interested party, and it explicitly states, 'A further announcement will be made once the outcome of the Judicial Review is known.' This structure—a brief update on a specific, non-standard corporate event (legal matter) distributed via the official regulatory news wire—fits best under the general regulatory announcement category, RNS, as it is not a core financial report (10-K, IR, ER) or a specific corporate action like a dividend or management change. Given the document's nature as a direct regulatory wire feed, RNS is the most appropriate classification.
2022-10-07 English
Director/PDMR Shareholding
Director's Dealing Classification · 99% confidence The document is explicitly labeled with "RNS Number : 6693A" and contains language typical of regulatory news service announcements from the London Stock Exchange (LSE). The core content details a 'Director/PDMR Dealing' where the Chief Executive Officer purchased shares. This type of insider transaction disclosure falls directly under the definition of Director's Dealing (DIRS). Although it is distributed via RNS, the specific subject matter dictates the DIRS classification over the general RNS fallback.
2022-09-26 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is an official announcement disseminated via RNS (Regulatory News Service) and explicitly details share purchases made by the Chief Executive Officer (Chris Yates) and the Chairman (Dr Christopher Hand) of Abingdon Health plc. This type of filing, which reports personal share transactions by company directors and executives (insider trades), directly corresponds to the definition of 'Director's Dealing'. The presence of 'RNS Number', 'Director/PDMR Dealing', and detailed transaction tables confirms this classification. Therefore, the appropriate code is DIRS.
2022-09-16 English
Second Price Monitoring Extn
Net Asset Value Classification · 98% confidence The document is very short (1933 characters) and announces a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange, referencing RNS (Regulatory News Service). It does not contain detailed financial results, management changes, or formal reports like a 10-K or IR. Since it is a specific, non-standard regulatory announcement concerning trading mechanics, and it doesn't fit the definitions for AGM-R, 10-K, ER, DIV, etc., the most appropriate classification is the general regulatory fallback category, RNS (Regulatory Filings).
2022-08-15 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.